Sri J Obulareddy Institution Verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Associate Professor
University of Arkansas for Medical Sciences
faculty
COM | Internal Med Hem-Onc
Research Areas
Biography and Research Information
OverviewAI-generated summary
Sri J Obulareddy, Associate Professor in Internal Medicine, Hematology and Oncology at the University of Arkansas for Medical Sciences, investigates various aspects of cancer burden and trends. Recent publications include analyses of colorectal, tracheal, bronchus, and lung cancer trends in Asia Pacific and Southeast Asian regions, with projections for future deaths. Obulareddy also studies the burden of stomach cancer attributable to smoking in South Asia. Additionally, research has focused on diagnostic challenges in hematology, including a case of aplastic anemia mimicking myelofibrosis and a case of herpes simplex virus meningitis in an immunocompromised individual. Obulareddy has collaborated on five shared publications with colleagues at the University of Arkansas for Medical Sciences. Scholarship metrics include an h-index of 2, with 6 total publications and 21 total citations.
Metrics
- h-index: 2
- Publications: 6
- Citations: 21
Selected Publications
- 526P Burden and trends of tracheal, bronchus, and lung (TBL) cancer in Southeast Asia, East Asia, and Oceania from 1990-2019, and its projection of deaths to 2040: A benchmarking analysis (2023) DOI
- 177P Burden of stomach cancer attributable to smoking in South Asia from 1990-2019, its projection of deaths to 2040: A benchmarking and comparative analysis (2023) DOI
- 116P Burden and trends of colorectal cancer in high income Asia Pacific countries from 1990-2019 and its projections of deaths to 2040: A comparative analysis (2023) DOI
- Aplastic Anemia Mimicking Myelofibrosis: A Diagnostic Dilemma (2023) DOI
- A Case of Herpes Simplex Virus Meningitis in an Immunocompromised Individual: Avoiding Common Diagnostic Pitfalls (2023) DOI
Grants & Funding
- 276883 S2212, Shorter Anthracycline-Free Chemo Immunotherapy Adapted Topathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study SouthWest Oncology Group Principal Investigator
- 276883 S2212, Shorter Anthracycline-Free Chemo Immunotherapy Adapted Topathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study SouthWest Oncology Group Principal Investigator
- 276250 Alliance A011801,COMPASSHER2 Trials:COMPASSHER2 Residual Disease, A Double-Blinded, Phase III Randomized Trial of T-DM1&Placebo Compared with T-DM1 and Tucatinib Alliance for Clinical Trials in Oncology Principal Investigator
- 276250 Alliance A011801,COMPASSHER2 Trials:COMPASSHER2 Residual Disease, A Double-Blinded, Phase III Randomized Trial of T-DM1&Placebo Compared with T-DM1 and Tucatinib Alliance for Clinical Trials in Oncology Principal Investigator
- 276249 Alliance A012103, OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy Alliance for Clinical Trials in Oncology Principal Investigator
- 276249 Alliance A012103, OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy Alliance for Clinical Trials in Oncology Principal Investigator
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics